(NO IDC) AN MRNA MULTIVALENT APPROACH INCLUDING PRE-ERYTHROCYTIC-STAGE ANTIGENS AND MOSQUITO SALIVA ANTIGENS TO BROADEN THE IMMUNE TARGETS AGAINST MALARIA INFECTION
$549,526FY2025Defense Health AgencyDOD
Conserv Bioscience Limited
Conserv Bioscience Limited